---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-023444"
form_type: "8-K"
ticker: "ENVB"
cik: "0000890821"
company_name: "Enveric Biosciences, Inc."
filed_at: "2025-11-14T23:59:59+00:00"
generated_at: "2026-05-16T20:03:17.995861+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Enveric regains Nasdaq minimum bid price compliance; delisting risk removed

## Summary
- Received Nasdaq letter on Nov 12, 2025 confirming compliance with Listing Rule 5550(a)(2).
- Minimum bid price deficiency now considered closed by Nasdaq.
- No further action required; company remains listed on Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001493152-25-023444
- form_type: 8-K
- ticker: ENVB
- cik: 0000890821
- company_name: Enveric Biosciences, Inc.
- filed_at: 2025-11-14T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/890821/000149315225023444/0001493152-25-023444-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/890821/000149315225023444/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-023444
- JSON: https://secwatch.observer/filing/0001493152-25-023444.json
- Plain text: https://secwatch.observer/filing/0001493152-25-023444.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.